ExAblate 4000 Type 2.1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ExAblate 4000 Type 2.1, covering 2025-09-05 to 2025-09-05. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of Neuromodulation Using 'ExAblate 4000 Type 2.1' in Patients With Psychostimulant Use Disorder(PUD) [NA]